695 related articles for article (PubMed ID: 31542715)
1. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
[TBL] [Abstract][Full Text] [Related]
3. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.
Abdelrahman MA; Ibrahim HS; Nocentini A; Eldehna WM; Bonardi A; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2021 Jan; 209():112897. PubMed ID: 33038795
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.
Chandra KM; Goud NS; Arifuddin M; Alvala M; Alvala R; Angeli A; Supuran CT
Bioorg Med Chem Lett; 2021 May; 39():127877. PubMed ID: 33640442
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
De Luca L; Mancuso F; Ferro S; Buemi MR; Angeli A; Del Prete S; Capasso C; Supuran CT; Gitto R
Eur J Med Chem; 2018 Jan; 143():276-282. PubMed ID: 29197732
[TBL] [Abstract][Full Text] [Related]
6. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.
Narella SG; Shaik MG; Mohammed A; Alvala M; Angeli A; Supuran CT
Bioorg Chem; 2019 Jun; 87():765-772. PubMed ID: 30974299
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Sridhar Goud N; Argulwar OS; Soman J; Angeli A; Alvala M; Arifuddin M; Supuran CT
Bioorg Chem; 2020 Nov; 104():104272. PubMed ID: 32961467
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Angeli A; Argulwar OS; Tiwari PL; Arifuddin M; Supuran CT
Bioorg Chem; 2020 May; 98():103739. PubMed ID: 32193032
[TBL] [Abstract][Full Text] [Related]
10. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
[TBL] [Abstract][Full Text] [Related]
11. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
Chandak N; Ceruso M; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Alvala M; Arifuddin M; Angeli A; Supuran CT
Bioorg Chem; 2019 May; 86():386-392. PubMed ID: 30763885
[TBL] [Abstract][Full Text] [Related]
13. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
[TBL] [Abstract][Full Text] [Related]
14. Novel 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide based thiosemicarbazides as potent and selective inhibitors of tumor-associated human carbonic anhydrase IX and XII: Synthesis, cytotoxicity, and molecular modelling studies.
Demir-Yazıcı K; Trawally M; Bua S; Öztürk-Civelek D; Akdemir A; Supuran CT; Güzel-Akdemir Ö
Bioorg Chem; 2024 Mar; 144():107096. PubMed ID: 38290186
[TBL] [Abstract][Full Text] [Related]
15. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A
Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and in vitro evaluation of novel thiazole-coumarin hybrids as selective and potent human carbonic anhydrase IX and XII inhibitors.
Singh P; Nerella SG; Swain B; Angeli A; Ullah Q; Supuran CT; Arifuddin M
Int J Biol Macromol; 2024 May; 268(Pt 1):131548. PubMed ID: 38642682
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives.
Meleddu R; Deplano S; Maccioni E; Ortuso F; Cottiglia F; Secci D; Onali A; Sanna E; Angeli A; Angius R; Alcaro S; Supuran CT; Distinto S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):685-692. PubMed ID: 33602041
[TBL] [Abstract][Full Text] [Related]
18. Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII.
Buran K; Bua S; Poli G; Önen Bayram FE; Tuccinardi T; Supuran CT
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857344
[TBL] [Abstract][Full Text] [Related]
19. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
